Quarles & Brady 's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
- Penetration Testing In Healthcare: HIPAA And GDPR Requirements
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Advancing ALS Research With Digital Health Technologies
Explore how wearable, sensor-based digital health technologies can revolutionize ALS patient monitoring by reading our latest insights from the Digital Health Monthly scientific webinar series.
-
EDC Powers End-To-End Data Management In Pharma-Sponsored Trials
As clinical research moves toward adaptive, decentralized, and data-rich models, EDC remains the backbone that makes innovation operationally feasible.
-
Navigating Wearable Integration: Key Operational Considerations
Explore wearable devices' transformative potential and innovative capabilities for data collection, patient monitoring, and endpoint measurement.
-
RTSM/IRT In Clinical Trials: The Complete Guide
RTSM/IRT systems are essential to modern clinical trials. This guide explores how to implement and optimize them to boost efficiency, streamline operations, uphold study integrity, and ensure compliance.
-
How Paper And Electronic Source Data Meet ALCOA-C Principles
According to the Food and Drug Administration (FDA), data should meet certain fundamental elements of quality. If these best practices for source documentation aren’t followed, there is no valid evidence the test article is safe and effective.
-
Why Data Integrity Still Matters — Even As Clinical Trials Evolve
Data integrity remains essential for compliance and patient safety. Learn strategies to maintain accuracy and reliability as clinical research evolves toward more connected, technology-driven models.
-
How To Optimize Adherence Of Wearables In Your Clinical Research
Learn about the top three factors to consider when working to maximize protocol adherence and minimize missing data in a technology-enabled clinical trial.
-
One Day, Clinical Trials Will Represent The Real World
What needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.
-
Accelerating Site Activation: Examples From Novartis And IQVIA
As protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.
-
Rose Research Center Leans On Medrio To Simplify Workflows And Study Design
After experiencing paper processing issues, discover how a company transitioned to digital data collection by using Electronic Data Capture (EDC) and Electronic Patient Reported Outcomes (ePRO) solutions.